Gihwan Byeon, Min Soo Byun, Dahyun Yi, Joon Hyung Jung, Nayeong Kong, Yoonyoung Chang, Musung Keum, Gijung Jung, Hyejin Ahn, Jun-Young Lee, Yu Kyeong Kim, Koung Mi Kang, Chul-Ho Sohn, Dong Young Lee
{"title":"视觉和听觉障碍与阿尔茨海默氏症病理的不同关系","authors":"Gihwan Byeon, Min Soo Byun, Dahyun Yi, Joon Hyung Jung, Nayeong Kong, Yoonyoung Chang, Musung Keum, Gijung Jung, Hyejin Ahn, Jun-Young Lee, Yu Kyeong Kim, Koung Mi Kang, Chul-Ho Sohn, Dong Young Lee","doi":"10.9758/cpn.24.1169","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>We intended to investigate the relationships between visual sensory impairment (VSI) or auditory sensory impairment (ASI) and brain pathological changes associated with cognitive decline in older adults.</p><p><strong>Methods: </strong>We primarily tried to examine whether each sensory impairment is related to Alzheimer's disease (AD) pathology, specifically beta-amyloid (Aβ) deposition, through both cross-sectional and longitudinal approaches in cognitively unimpaired older adults. Self-report questionnaires on vision and hearing status were administered at the baseline. Neuroimaging scans including brain [<sup>11</sup>C] Pittsburgh Compound B PET and MRI, as well as clinical assessments, were performed at baseline and 2-year follow-up.</p><p><strong>Results: </strong>Cross-sectional analyses showed that the VSI-positive group had significantly higher Aβ deposition than the VSI-negative group, whereas there was no significant association between ASI positivity and Aβ deposition. Longitudinal analyses revealed that VSI positivity at baseline was significantly associated with increased Aβ deposition over 2 years (β = 0.153, <i>p</i> = 0.025), although ASI positivity was not (β = 0.045, <i>p</i> = 0.518). VSI positivity at baseline was also significantly associated with greater atrophic changes in AD-related brain regions over the 2-year follow-up period (β = -0.207, <i>p</i> = 0.005), whereas ASI positivity was not (β = 0.024, <i>p</i> = 0.753). Neither VSI nor ASI positivity was related to cerebrovascular injury, as measured based on the white matter hyperintensity volume.</p><p><strong>Conclusion: </strong>The findings suggest that VSI is probably related to AD-specific pathological changes, which possibly mediate the reported relationship between VSI and cognitive decline. In contrast, ASI appears not associated with AD pathologies but may contribute to cognitive decline via other mechanisms.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11494423/pdf/","citationCount":"0","resultStr":"{\"title\":\"Visual and Auditory Sensory Impairments Differentially Relate with Alzheimer's Pathology.\",\"authors\":\"Gihwan Byeon, Min Soo Byun, Dahyun Yi, Joon Hyung Jung, Nayeong Kong, Yoonyoung Chang, Musung Keum, Gijung Jung, Hyejin Ahn, Jun-Young Lee, Yu Kyeong Kim, Koung Mi Kang, Chul-Ho Sohn, Dong Young Lee\",\"doi\":\"10.9758/cpn.24.1169\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>We intended to investigate the relationships between visual sensory impairment (VSI) or auditory sensory impairment (ASI) and brain pathological changes associated with cognitive decline in older adults.</p><p><strong>Methods: </strong>We primarily tried to examine whether each sensory impairment is related to Alzheimer's disease (AD) pathology, specifically beta-amyloid (Aβ) deposition, through both cross-sectional and longitudinal approaches in cognitively unimpaired older adults. Self-report questionnaires on vision and hearing status were administered at the baseline. Neuroimaging scans including brain [<sup>11</sup>C] Pittsburgh Compound B PET and MRI, as well as clinical assessments, were performed at baseline and 2-year follow-up.</p><p><strong>Results: </strong>Cross-sectional analyses showed that the VSI-positive group had significantly higher Aβ deposition than the VSI-negative group, whereas there was no significant association between ASI positivity and Aβ deposition. Longitudinal analyses revealed that VSI positivity at baseline was significantly associated with increased Aβ deposition over 2 years (β = 0.153, <i>p</i> = 0.025), although ASI positivity was not (β = 0.045, <i>p</i> = 0.518). VSI positivity at baseline was also significantly associated with greater atrophic changes in AD-related brain regions over the 2-year follow-up period (β = -0.207, <i>p</i> = 0.005), whereas ASI positivity was not (β = 0.024, <i>p</i> = 0.753). Neither VSI nor ASI positivity was related to cerebrovascular injury, as measured based on the white matter hyperintensity volume.</p><p><strong>Conclusion: </strong>The findings suggest that VSI is probably related to AD-specific pathological changes, which possibly mediate the reported relationship between VSI and cognitive decline. In contrast, ASI appears not associated with AD pathologies but may contribute to cognitive decline via other mechanisms.</p>\",\"PeriodicalId\":2,\"journal\":{\"name\":\"ACS Applied Bio Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-11-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11494423/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Bio Materials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.9758/cpn.24.1169\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/8/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.9758/cpn.24.1169","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/16 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
摘要
目的我们旨在研究视觉感觉障碍(VSI)或听觉感觉障碍(ASI)与老年人认知能力下降相关的脑病理变化之间的关系:我们主要试图通过横断面和纵向方法,在认知功能未受损的老年人中研究每种感觉障碍是否与阿尔茨海默病(AD)病理,特别是β-淀粉样蛋白(Aβ)沉积有关。在基线期对视力和听力状况进行自我报告问卷调查。在基线和两年随访期间进行了神经影像扫描,包括脑[11C]匹兹堡化合物B正电子发射计算机断层扫描和核磁共振成像,以及临床评估:横断面分析表明,VSI 阳性组的 Aβ 沉积明显高于 VSI 阴性组,而 ASI 阳性与 Aβ 沉积之间无明显关联。纵向分析显示,基线 VSI 阳性与 2 年后 Aβ 沉积增加有明显相关性(β = 0.153,p = 0.025),而 ASI 阳性则没有相关性(β = 0.045,p = 0.518)。基线 VSI 阳性与 2 年随访期间 AD 相关脑区更大的萎缩性变化也显著相关(β = -0.207,p = 0.005),而 ASI 阳性则不相关(β = 0.024,p = 0.753)。根据白质高密度体积测量,VSI 和 ASI 阳性均与脑血管损伤无关:研究结果表明,VSI可能与AD特异性病理改变有关,这可能是VSI与认知能力下降之间关系的中介。相比之下,ASI 似乎与 AD 病理变化无关,但可能通过其他机制导致认知能力下降。
Visual and Auditory Sensory Impairments Differentially Relate with Alzheimer's Pathology.
Objective: We intended to investigate the relationships between visual sensory impairment (VSI) or auditory sensory impairment (ASI) and brain pathological changes associated with cognitive decline in older adults.
Methods: We primarily tried to examine whether each sensory impairment is related to Alzheimer's disease (AD) pathology, specifically beta-amyloid (Aβ) deposition, through both cross-sectional and longitudinal approaches in cognitively unimpaired older adults. Self-report questionnaires on vision and hearing status were administered at the baseline. Neuroimaging scans including brain [11C] Pittsburgh Compound B PET and MRI, as well as clinical assessments, were performed at baseline and 2-year follow-up.
Results: Cross-sectional analyses showed that the VSI-positive group had significantly higher Aβ deposition than the VSI-negative group, whereas there was no significant association between ASI positivity and Aβ deposition. Longitudinal analyses revealed that VSI positivity at baseline was significantly associated with increased Aβ deposition over 2 years (β = 0.153, p = 0.025), although ASI positivity was not (β = 0.045, p = 0.518). VSI positivity at baseline was also significantly associated with greater atrophic changes in AD-related brain regions over the 2-year follow-up period (β = -0.207, p = 0.005), whereas ASI positivity was not (β = 0.024, p = 0.753). Neither VSI nor ASI positivity was related to cerebrovascular injury, as measured based on the white matter hyperintensity volume.
Conclusion: The findings suggest that VSI is probably related to AD-specific pathological changes, which possibly mediate the reported relationship between VSI and cognitive decline. In contrast, ASI appears not associated with AD pathologies but may contribute to cognitive decline via other mechanisms.